Atomoxetine in the Treatment of Binge Eating Disorder

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Binge-eating Disorder
Interventions
DRUG

atomoxetine

Trial Locations (1)

45267-0559

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER

NCT00327834 - Atomoxetine in the Treatment of Binge Eating Disorder | Biotech Hunter | Biotech Hunter